Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Clinical Oncology

• Publication date

  1990-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1990.8.4.638PMID 2313333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease.

  1989cited by this paper
• Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.

  1989cited by this paper
• Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.

  1989cited by this paper
• The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomas.

  1988cited by this paper
• Interpretation of clinical trials in diffuse large-cell lymphoma.

  1988cited by this paper
• Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

  1988cited by this paper
• Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

  1988cited by this paper
• Autologous bone marrow transplantation for patients with poor-prognosis lymphoma.

  1988cited by this paper
• Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.

  1988cited by this paper
• Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in hodgkin's disease. An analysis of long‐term follow‐up

  1988cited by this paper
• Prognostic factors in Hodgkin's disease: implications for modern treatment (review).

  1988cited by this paper
• Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

  1988cited by this paper
• The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.

  1988cited by this paper
• Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.

  1987cited by this paper
• Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue.

  1987cited by this paper
• A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin's lymphoma.

  1987cited by this paper
• Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.

  1987cited by this paper
• European School of Oncology: management of non-Hodgkin's lymphomas: conclusions of the European School of Oncology Meeting, 1986.

  1987cited by this paper
• Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

  1987cited by this paper
• High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

  1987cited by this paper
• Salvage treatment for Hodgkin's disease in relapse.

  1987cited by this paper
• Chemotherapy in patients who fail radiotherapy for diffuse aggressive non-Hodgkin's lymphoma.

  1987cited by this paper
• Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease.

  1987cited by this paper
• Clinical studies of ABMT in non-Hodgkin's lymphoma.

  1986cited by this paper
• High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

  1986cited by this paper
• The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.

  1986cited by this paper
• High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma.

  1986cited by this paper
• Clinical studies of autologous bone marrow transplantation in Hodgkin's disease.

  1986cited by this paper
• High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma.

  1986cited by this paper
• Controlled rate freezing of human marrow in a constant temperature cooling gradient in air.

  1986cited by this paper
• Marrow harvesting for autologous marrow transplantation.

  1985cited by this paper
• The Karnofsky performance status scale: An examination of its reliability and validity in a research setting

  1984cited by this paper
• Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.

  1983cited by this paper
• IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.

  1982cited by this paper
• Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.

  1982cited by this paper
• Asymptotically efficient rank invariant test procedure (with discussion).

  1972cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper
• Technique for human marrow grafting.

  1970cited by this paper
• The pathology and nomenclature of Hodgkin's disease.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Disease characteristics of diffuse large B‐cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience

  2020cites this paper
• Response to hyperfractionated accelerated radiotherapy in chemotherapy-refractory non-Hodgkin lymphoma

  2020cites this paper
• A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03).

  2019cites this paper
• Preparative regimens for lymphoma

  2015cites this paper
• Histone deacetylase inhibitors in adult patients with diffuse large b-cell lymphoma relapsed/refractory: a phase II study with Panobinostat

  2015cites this paper
• Diffuse large B-cell lymphoma.

  2013cites this paper
• Stem cell transplantation for non-hodgkin's lymphomas

  2013cites this paper
• lymphoma hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin Early lymphocyte recovery predicts superior survival after autologous

  2013cites this paper
• transplantation high- dose busulfan or total-body irradiation and bone marrow Pregnancies following high-dose cyclophosphamide with or without

  2011cites this paper
• LACE‐conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B‐cell lymphoma: treatment outcome and risk factor analysis from a single centre

  2011cites this paper
• A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation

  2010influential citation
• Prognostic Factors in N on-H odgkin’s Lym phom a Patients T reated by A utologous Stem C ell T ransplantation: A Single C enter Experience

  2009cites this paper
• Medical management update: Non-Hodgkin lymphoma.

  2009cites this paper
• Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

  2008cites this paper
• Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement

  2008cites this paper
• Immune reconstitution after autologous hematopoietic stem cell transplantation

  2007cites this paper
• Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.

  2007cites this paper
• Dexa-BEAM as salvage therapy in patients with primary refractory aggressive Non-Hodgkin lymphoma

  2007cites this paper
• Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphoma.

  2006cites this paper
• VIM3‐ARA C: An effective salvage regimen in refractory or recurrent aggressive non hodgkin's lymphoma. A report on 18 cases

  2006cites this paper
• Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWO

  2006cites this paper
• AUTOLOGOUS BONE MARROW TRANSPLANTATION IN SOUTHWEST ONCOLOGY GROUP STUDY ADULTS WITH NON-HODGKIN’S LYMPHOMA: A

  2006cites this paper
• Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin’s Lymphomas

  2005cites this paper
• Nodal aggressive non-Hodgkin’s lymphoma in the adult: a review article

  2005cites this paper
• Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study

  2005cites this paper
• Prognostic factors in non-Hodgkin's lymphoma patients treated by autologous stem cell transplantation: a single center experience.

  2005cites this paper
• Hematopoietic stem cell gene therapy with drug resistance genes: an update

  2005cites this paper
• Detection and Relevance of Minimal Disease in Lymphomas

  2004cites this paper
• MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA: A REPORT OF THE INTERNATIONAL BONE MARROW TRANSPLANT REGISTRY Running head: Allogeneic transplants after autologous failure For Submission to BLOOD, Trans

  2004cites this paper
• Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.

  2004cites this paper
• Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma.

  2004cites this paper
• Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

  2004influential citation
• Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation

  2004cites this paper
• High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma

  2003cites this paper
• The Role of Surveillance CT Scans in Patients with Diffuse Large B-cell Non-Hodgkin's Lymphoma

  2003cites this paper
• Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.

  2003cites this paper
• Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.

  2003cites this paper
• Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?

  2003cites this paper
• ‘Relative’ chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma

  2002cites this paper
• The choice of allogeneic or autologous hematopoietic transplantation for NHL.

  2002cites this paper
• Outcome of Relapsed Non-Hodgkin's Lymphoma Patients After Allogeneic and Autologous Transplantation

  2002cites this paper
• Changing role and decreasing size: Current trends in radiotherapy for hodgkin’s disease

  2002cites this paper
• MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging

  2002cites this paper
• Stem Cell Transplantation for Aggressive Non-Hodgkin ’ s Lymphoma

  2001cites this paper
• High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma.

  2001cites this paper
• Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

  2001cites this paper
• Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

  2001cites this paper
• Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older

  2001cites this paper
• [Therapy intensification with autologous transplantation in non-Hodgkin's lymphomas].

  2001cites this paper
• Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

  2001cites this paper
• Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation

  2001cites this paper
• CD34+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications

  2001cites this paper
• Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non‐Hodgkin's lymphoma: a single‐centre experience

  2001cites this paper
• Radiation myelitis following allogeneic stem cell transplantation and consolidation radiotherapy for non-Hodgkin's lymphoma

  2000cites this paper
• The management of adult aggressive non-Hodgkin's lymphomas.

  2000cites this paper
• A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

  2000cites this paper
• Autologous Transplantation for Hodgkin’s Disease

  2000cites this paper
• Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.

  2000cites this paper
• Is Autologous Transplantation for Non-Hodgkin’s Lymphoma Underutilized?

  2000cites this paper
• Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience

  2000cites this paper
• High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors

  2000cites this paper
• High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis.

  2000cites this paper
• Costs of Peripheral Blood Progenitor Cell Transplantation Using Whole Blood Mobilised by Filgrastim as Compared With Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma

  1999cites this paper
• Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

  1999cites this paper
• High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin’s lymphoma

  1999cites this paper
• High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin

  1999cites this paper
• Mitoxantrone-DHAP with GM-CSF: an active but myelosuppressive salvage therapy for relapsed/refractory aggressive non-Hodgkin's lymphoma.

  1999cites this paper
• The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases

  1999cites this paper
• High‐dose therapy for Hodgkin's disease

  1999cites this paper
• Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin’s lymphoma: results from the University of Nebraska Medical Center 1989 to 1995

  1999cites this paper
• Transplantation in Lymphoma

  1999cites this paper
• The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma

  1999cites this paper
• Total-body irradiation in the conditioning regimens for autologous stem cell transplantation in lymphoproliferative diseases.

  1999cites this paper
• Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma.

  1999cites this paper
• Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas.

  1999cites this paper
• High dose therapy for Hodgkin's disease.

  1999cites this paper
• High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma.

  1998cites this paper
• Blood and marrow transplantation in relapsed or refractory non-Hodgkin's lymphoma.

  1998cites this paper
• [Intensive therapy in non-Hodgkins lymphoma. Indications and modalities].

  1998cites this paper
• Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma. Type of cells, optimal mobilization of stem cells--positive and negative selection.

  1998cites this paper
• Peripheral Blood Progenitor Cell Mobilization: A Clinical Review

  1998cites this paper
• High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.

  1998cites this paper
• Stem Cell Transplants for Hematopoietic Malignancies

  1998cites this paper
• Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial.

  1998cites this paper
• Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin's lymphoma.

  1998cites this paper
• Hematopoietic Cell Transplantation for Multiple Myeloma.

  1998cites this paper
• Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma.

  1998cites this paper
• Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.

  1998cites this paper
• High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.

  1997cites this paper
• Multiple cycles of aggressive chemotherapy prior to autologous peripheral stem cell transplantation for lymphoma.

  1997cites this paper
• The development of bone marrow transplantation as a treatment for patients with lymphoma--twentieth Richard and Hinda Rosenthal Foundation Award Lecture.

  1997cites this paper
• Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation

  1997cites this paper
• Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point

  1997cites this paper
• Hochdosistherapie mit Stammzelltransplantation bei Patienten mit indolenten Non-Hodgkin-Lymphomen

  1997cites this paper
• Autologous bone marrow versus non‐mobilized peripheral blood stem cell transplantation for lymphoid malignancies: A prospective, comparative trial

  1997cites this paper
• Initial Trial of PIXY 321 Following Autologous Bone Marrow Transplantation

  1997cites this paper
• Interleukin-12 induced cytolytic activity in lymphocytes from recipients of autologous and allogeneic stem cell transplants

  1997cites this paper
• High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers

  1997cites this paper
• Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

  1997cites this paper
• Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.

  1997cites this paper